Celiac Disease Triggered by Intestinal Viruses
|
By LabMedica International staff writers Posted on 14 Jul 2016 |

Image: A histology of the small intestinal mucosa; the normal is on the left. The mucosa involved by celiac disease (sprue) at the right has blunting and flattening of villi (Photo courtesy of the CDC).
Digestive problems, severe inflammation of the small intestine and nutritional deficiencies leading to anemia and osteoporosis force patients of the autoimmune condition celiac disease to follow a strict gluten-free diet for life.
In celiac patients, gluten, a protein contained in many types of cereals, causes the immune system to attack the intestine and the number of people being diagnosed with celiac disease has increased significantly in recent decades and that those affected by the condition are at greater risk of developing other autoimmune diseases; however, less is known about the actual triggers of the disease.
Scientists at the University of Naples Federico II (Italy) and their colleagues analyzed samples of blood serum and 150 small-intestine biopsies from celiac patients and compared them with those of a healthy control group. Serum samples from at least 50 controls (CTR) and 50 celiac disease (CD) patients were tested to detect anti-reovirus antibodies, in a plaque-reduction neutralization assay. Ribonucleic acid (RNA) from duodenal biopsies of 20 CTR and 20 CD patients was tested for interferon-alpha (IFNα), IFN-β and MX Dynamin Like GTPase 1(Mx1), an IFN inducible gene, expression by quantataive polymerase chain reactin (qPCR). The Interferon-induced GTP-binding protein Mx1 (MxA) and interleukin-15 (IL-15) protein expression was evaluated by immunohistochemistry (IHC) in duodenal paraffin-embedded sections.
The team found that a higher number of CD patients showed significantly elevated anti-reovirus serum titers compared to CTR, suggesting that an increased frequency of infections over time occurred in those subjects. An up-regulation of the type-1 IFN pathway was supported by higher levels of Mx-1, IFN-α and IFN-β found in small intestinal biopsies of CD patients compared to controls as well as by the increased MxA protein levels, as assessed by Western blot and IHC shown in the mucosa of CD patients.
Reinhard Hinterleitner, a co-author of the study, said, “Intestinal viruses upset the small intestine and regulatory T lymphocytes can be transformed into pro-inflammatory T lymphocytes as a result. The dendritic cells are also alerted by the infection. If gluten containing food is consumed at the same time as a viral infection occurs, the already alerted dendritic cells also present gluten antigens to the T lymphocytes.” The study was published originally in the April 2016 issue of the journal Gastroenterology.
Related Links:
University of Naples Federico II
In celiac patients, gluten, a protein contained in many types of cereals, causes the immune system to attack the intestine and the number of people being diagnosed with celiac disease has increased significantly in recent decades and that those affected by the condition are at greater risk of developing other autoimmune diseases; however, less is known about the actual triggers of the disease.
Scientists at the University of Naples Federico II (Italy) and their colleagues analyzed samples of blood serum and 150 small-intestine biopsies from celiac patients and compared them with those of a healthy control group. Serum samples from at least 50 controls (CTR) and 50 celiac disease (CD) patients were tested to detect anti-reovirus antibodies, in a plaque-reduction neutralization assay. Ribonucleic acid (RNA) from duodenal biopsies of 20 CTR and 20 CD patients was tested for interferon-alpha (IFNα), IFN-β and MX Dynamin Like GTPase 1(Mx1), an IFN inducible gene, expression by quantataive polymerase chain reactin (qPCR). The Interferon-induced GTP-binding protein Mx1 (MxA) and interleukin-15 (IL-15) protein expression was evaluated by immunohistochemistry (IHC) in duodenal paraffin-embedded sections.
The team found that a higher number of CD patients showed significantly elevated anti-reovirus serum titers compared to CTR, suggesting that an increased frequency of infections over time occurred in those subjects. An up-regulation of the type-1 IFN pathway was supported by higher levels of Mx-1, IFN-α and IFN-β found in small intestinal biopsies of CD patients compared to controls as well as by the increased MxA protein levels, as assessed by Western blot and IHC shown in the mucosa of CD patients.
Reinhard Hinterleitner, a co-author of the study, said, “Intestinal viruses upset the small intestine and regulatory T lymphocytes can be transformed into pro-inflammatory T lymphocytes as a result. The dendritic cells are also alerted by the infection. If gluten containing food is consumed at the same time as a viral infection occurs, the already alerted dendritic cells also present gluten antigens to the T lymphocytes.” The study was published originally in the April 2016 issue of the journal Gastroenterology.
Related Links:
University of Naples Federico II
Latest Molecular Diagnostics News
- Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
- Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
- Two-in-One DNA Analysis Improves Diagnostic Accuracy While Saving Time and Costs
- “Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
- New Tool Maps Chromosome Shifts in Cancer Cells to Predict Tumor Evolution
- Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
- Newly-Identified Parkinson’s Biomarkers to Enable Early Diagnosis Via Blood Tests
- New Blood Test Could Detect Pancreatic Cancer at More Treatable Stage
- Liquid Biopsy Could Replace Surgical Biopsy for Diagnosing Primary Central Nervous Lymphoma
- New Tool Reveals Hidden Metabolic Weakness in Blood Cancers
- World's First Blood Test Distinguishes Between Benign and Cancerous Lung Nodules
- Rapid Test Uses Mobile Phone to Identify Severe Imported Malaria Within Minutes
- Gut Microbiome Signatures Predict Long-Term Outcomes in Acute Pancreatitis
- Blood Test Promises Faster Answers for Deadly Fungal Infections
- Blood Test Could Detect Infection Exposure History
- Urine-Based MRD Test Tracks Response to Bladder Cancer Surgery
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







